
EasyPack
A bogus connection to major retailers is just the beginning.
Bubak et al v. GOLO, LLC
21-cv-492, E.D. Cal.
(March 2021)
GOLO’s Release Supplement
Implying that the supplement mitigates and prevents diabetes, heart disease, and Alzheimer’s disease by claiming that it is “the Natural Solution to Insulin Resistance”
Misleadingly marketing the supplement as “Clinically Proven” when the company relies on pilot studies that it paid for and that have not been peer reviewed or published in legitimate scientific publications
Pending
A bogus connection to major retailers is just the beginning.
Don’t pay for free online government forms.
Misleading campaigns highlight this year’s big ad event.
Consumers may want to see through many of this company’s claims.
It won’t get any easier to cancel those annoying subscriptions.